{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.666.5.2350",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2016-03-31T01:00:12.000-04:00"
  },
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2350",
  "version" : "20160331",
  "name" : "Immunocompromised Therapies I9",
  "status" : "active",
  "date" : "2016-03-31T01:00:12-04:00",
  "publisher" : "Lantana EH Steward",
  "compose" : {
    "include" : [{
      "system" : "http://hl7.org/fhir/sid/icd-9-cm",
      "version" : "2013",
      "concept" : [{
        "code" : "00.10",
        "display" : "Implantation of chemotherapeutic agent"
      },
      {
        "code" : "00.15",
        "display" : "High-dose infusion interleukin-2 [IL-2]"
      },
      {
        "code" : "17.70",
        "display" : "Intravenous infusion of clofarabine"
      },
      {
        "code" : "99.25",
        "display" : "Injection or infusion of cancer chemotherapeutic substance"
      },
      {
        "code" : "99.28",
        "display" : "Injection or infusion of biological response modifier [BRM] as an antineoplastic agent"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:dece379f-8ab5-4a40-bf2b-82ac7c02cb33",
    "timestamp" : "2022-09-27T21:43:08-04:00",
    "total" : 5,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://hl7.org/fhir/sid/icd-9-cm",
      "version" : "2013",
      "code" : "00.10",
      "display" : "Implantation of chemotherapeutic agent"
    },
    {
      "system" : "http://hl7.org/fhir/sid/icd-9-cm",
      "version" : "2013",
      "code" : "00.15",
      "display" : "High-dose infusion interleukin-2 [IL-2]"
    },
    {
      "system" : "http://hl7.org/fhir/sid/icd-9-cm",
      "version" : "2013",
      "code" : "17.70",
      "display" : "Intravenous infusion of clofarabine"
    },
    {
      "system" : "http://hl7.org/fhir/sid/icd-9-cm",
      "version" : "2013",
      "code" : "99.25",
      "display" : "Injection or infusion of cancer chemotherapeutic substance"
    },
    {
      "system" : "http://hl7.org/fhir/sid/icd-9-cm",
      "version" : "2013",
      "code" : "99.28",
      "display" : "Injection or infusion of biological response modifier [BRM] as an antineoplastic agent"
    }]
  }
}